These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21844282)

  • 1. Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up.
    Frazzitta G; Bertotti G; Riboldazzi G; Turla M; Uccellini D; Boveri N; Guaglio G; Perini M; Comi C; Balbi P; Maestri R
    Neurorehabil Neural Repair; 2012 Feb; 26(2):144-50. PubMed ID: 21844282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehabilitation improves dyskinesias in Parkinsonian patients: a pilot study comparing two different rehabilitative treatments.
    Frazzitta G; Bertotti G; Morelli M; Riboldazzi G; Pelosin E; Balbi P; Boveri N; Comi C; Turla M; Leva S; Felicetti G; Maestri R
    NeuroRehabilitation; 2012; 30(4):295-301. PubMed ID: 22672943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive rehabilitation treatment in early Parkinson's disease: a randomized pilot study with a 2-year follow-up.
    Frazzitta G; Maestri R; Bertotti G; Riboldazzi G; Boveri N; Perini M; Uccellini D; Turla M; Comi C; Pezzoli G; Ghilardi MF
    Neurorehabil Neural Repair; 2015 Feb; 29(2):123-31. PubMed ID: 25038064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: a comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training.
    Frazzitta G; Maestri R; Uccellini D; Bertotti G; Abelli P
    Mov Disord; 2009 Jun; 24(8):1139-43. PubMed ID: 19370729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
    Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
    Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
    Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor complications in Parkinson's disease: ten year follow-up study.
    López IC; Ruiz PJ; Del Pozo SV; Bernardos VS
    Mov Disord; 2010 Dec; 25(16):2735-9. PubMed ID: 20931632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study.
    Herman T; Giladi N; Gruendlinger L; Hausdorff JM
    Arch Phys Med Rehabil; 2007 Sep; 88(9):1154-8. PubMed ID: 17826461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of step training and rhythmic auditory stimulation on functional performance in Parkinson patients.
    Kadivar Z; Corcos DM; Foto J; Hondzinski JM
    Neurorehabil Neural Repair; 2011 Sep; 25(7):626-35. PubMed ID: 21436393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
    N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of motor imagery and physical practice in group treatment applied to subjects with Parkinson's disease.
    Tamir R; Dickstein R; Huberman M
    Neurorehabil Neural Repair; 2007; 21(1):68-75. PubMed ID: 17172556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
    Larsen JP; Boas J
    Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.